• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

AJMC® in the Press, January 24, 2025

News
Article

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

An article from News Medical & Life Sciences referenced a study published in the December 2024 issue of The American Journal of Managed Care® (AJMC®). The study, “Out-of-Pocket Spending for Cardiac Rehabilitation and Adherence Among US Adults,” found that those who had higher out-of-pocket spending had lower adherence to cardiac rehabilitation.

An article from Becker’s GI & Endoscopy highlighted an article published on AJMC.com, the website of AJMC. The article highlighted, “Prioritizing Blood-Based Colorectal Cancer Tests May Lead to Higher Costs, Worse Outcomes,” reported on a study that found that fecal immunochemical tests were more effective in screening for colorectal cancer in both outcomes and in cost.

Related Videos
Experts warn that ICHRAs could either stabilize or destabilize the individual market, depending on which workers employers shift into these plans.
Aleata Postell, SVP of pharmacy business development, CenterWell Pharmacy
ASCO GI 2026 Recap
Jo Varshney, PhD, DVM, CEO and founder of VeriSIM Life
Dr Marco del Riccio
Bhavana (Tina) Bhatnagar, DO, West Virginia University Cancer Institute at Wheeling Hospital
Related Content
Woman telehealth doctor phone - StockPhotoPro - stock.adobe.com.jpeg

Trump Terminates Hundreds of SAMHSA Grants, Threatening Mental Health, Addiction Services Nationwide

January 14th 2026
Article

Federal grant terminations by SAMHSA threaten vital mental health and substance use services, risking lives amid rising suicide rates and addiction crises.

Read More

Managed Care Cast

Managed Care Cast News Roundup: January 13, 2026

January 13th 2026
Podcast

This week's news roundup covers updates in health policy, technology, and access to pharmaceuticals.

Listen

“For younger, high-risk patients, zanubrutinib combined with R-BAC showed encouraging efficacy and high MRD negativity rates in a small cohort, suggesting its potential to improve prognosis and showing promise as a first-line treatment option for this population,” the authors concluded. | Image credit: fotogurmespb - stock.adobe.com

Frontline Zanubrutinib-Based Therapy Shows High CR Rates in Older Patients, High-Risk MCL

January 14th 2026
Article

Frontline zanubrutinib regimens achieved objective response rates of 100% with deep remissions in older patients and younger, high-risk patients with MCL.

Read More

2026 Health Care Predictions: AI, GLP-1s, MAHA, DEI: Sachin H. Jain, MD, MBA

2026 Health Care Predictions: AI, GLP-1s, MAHA, DEI: Sachin H. Jain, MD, MBA

January 1st 2026
Podcast

Sachin H. Jain, MD, MBA, discusses 2026 health care predictions, including AI adoption, GLP-1 demand, MAHA growth, DEI’s return, and policy shifts.

Listen

Cardiovascular system - appledesign - stock.adobe.com.jpg

Prediabetes Plus Subclinical Myocardial Injury, Stress Significantly Increases HF Risk

January 14th 2026
Article

Adults with hypertension who have prediabetes and subclinical myocardial injury or stress face a higher risk of incident heart failure, a study suggests.

Read More

Vision issues | Image credit: Miroslav110 - stock.adobe.com

Central Macular Thickness Reduced With Combined Phacoemulsification With Dexamethasone Implants

January 14th 2026
Article

Visual acuity and central macular thickness improved in patients with diabetic macular edema who used combined phacoemulsification and intravitreal dexamethasone implants.

Read More

© 2026 MJH Life Sciences
AJMC®
All rights reserved.